ArticleCureus2026
Mid-Term Outcomes of Isolated Trochlear Arthroplasty for Patellofemoral Arthritis: A Joint-Preserving Alternative to Complete Patellofemoral Replacement.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Trochlea-only arthroplasty (TOA) is a conservative surgical approach for isolated patellofemoral arthritis, aimed at preserving the native patella and avoiding complications associated with its resurfacing. This study evaluates the mid-term survivorship, functional outcomes, and revision profile of patients undergoing TOA and compares outcomes with historical data from conventional patellofemoral arthroplasty (PFA). Methods We retrospectively reviewed 50 patients who underwent isolated TOA between 2008 and 2019 by a single surgeon. A medial parapatellar approach was used, with intraoperative assessment of the joint. The decision to retain the native patella was made irrespective of the extent of arthritis in the patella. All patients underwent patelloplasty and circum-patellar neurectomy without resurfacing. Implant survival was evaluated using Kaplan-Meier analysis, and factors influencing revision were assessed using Cox proportional hazards modelling. Patient-reported outcomes were collected using the Kujala score in a subset of patients with unrevised implants. Results The overall implant survivorship was 82% at a mean follow-up of 9.2 years. Nine (18%) patients required revision, most commonly due to progression of tibiofemoral arthritis. Revisions included patellar resurfacing, staged medial unicompartmental knee replacement, and conversion to total knee arthroplasty. Age and sex were not significant predictors of revision. The mean Kujala score in 13 (32%) unrevised patients was 56.1, with no reports of instability or significant flexion deficits. No patients with known revisions were contacted for patient-reported outcomes. Conclusion TOA is a viable joint-preserving surgical option for selected patients with isolated patellofemoral arthritis. It avoids the complications associated with patellar resurfacing and maintains satisfactory mid-term survivorship comparable to published literature. TOA may serve as a procedural bridge between conservative management and full PFA, allowing for a stepwise and anatomically conservative approach. Further prospective studies are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.